Profitelligence Profitelligence · Filing Ledger Sign up free →

27 filings · most recent first

WST 8-K Filings

West Pharmaceutical Services Reports Strong Q2 2026 Results And Raises Guidance West Pharmaceutical Services Amends Technology And Distribution Agreements With West Pharmaceutical Services Appoints Michel Lagarde As New Ceo West Pharmaceutical Services Discloses Material Cybersecurity Incident West Pharmaceutical Services Reports Strong Q1 2026 Results And Raises Fullyear Eric M Green Announces Retirement As Ceo Of West Pharmaceutical Services West Pharmaceutical Services Reports Strong 2025 Results And 2026 Guidance West Pharmaceutical Services Reports Q3 2025 Earnings Beat And Raises Guidance West Pharmaceutical Services Announces Senior Executive Departure West Pharmaceutical Announces Secondquarter 2025 Results And Updates Guidance West Pharma Appoints New Cfo Mcmahon West Pharmaceutical Services Inc Updates Incentive Compensation Plan Shareholders Approve Proposals At West Pharmaceutical Services 2025 Annual West Pharmaceutical Announces Key Leadership Changes West Pharmaceutical Services Reports Firstquarter 2025 Results Increases Cindy Reissclark Departs As Senior Vice President And Chief Commercial Officer West Pharmaceutical Services Announces Departure Of Chief Commercial Officer West Pharmaceutical Announces 2024 Results And 2025 Guidance West Pharmaceutical Services Authorizes Share Repurchase Program West Pharmaceutical Services Appoints Janet Haugen To Board Of Directors West Pharmaceutical Services Announces Thirdquarter 2024 Results And Increases West Pharmaceutical Services Announces Cto Resignation West Pharmaceutical Services Updates Q2 2024 Financial Results And Guidance West Pharmaceutical Services Inc Amends Credit Agreement To Establish New Term West Pharmaceutical Services Announces Cfo Role Update And Shareholder Meeting West Pharmaceutical Announces Q1 2024 Results And Dividend West Pharmaceutical Reports Q4 And Fullyear 2023 Results Provides 2024 Guidance
WST full research: price, insiders, financials →